Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model.

Modern rheumatology / the Japan Rheumatism Association

Volumn 20, Issue 4, 2010, Pages 381-388

  Setoguchi, Chikako ^a   Tsuji, Fumio ^b   Katsuta, Osamu ^b   Okamoto, Masahiro ^b   Aono, Hiroyuki ^b  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BUCILLAMINE; CYSTEINE; DRUG DERIVATIVE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTHRITIS; ARTICLE; BLOOD; DISEASE MODEL; DRUG COMBINATION; DRUG POTENTIATION; FEMALE; IMMUNOLOGY; LEWIS RAT; PATHOLOGY; RAT; RHEUMATOID ARTHRITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYSTEINE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; RATS; RATS, INBRED LEW; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 78349283097     PISSN: None     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0292-8     Document Type: Article

References (0)